Int. J. Mol. Sci. 2013, 14(4), 8213-8227; doi:10.3390/ijms14048213
Review

The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer

email and * email
Received: 27 February 2013; in revised form: 28 March 2013 / Accepted: 1 April 2013 / Published: 15 April 2013
(This article belongs to the Special Issue Genes and Pathways in the Pathogenesis of Ovarian Cancer)
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract: Ovarian cancer is the fifth most common cause of death due to cancer in women despite being the tenth in incidence. Unfortunately, the five-year survival rate is only 45%, which has not improved much in the past 30 years. Even though the majority of women have successful initial therapy, the low rate of survival is due to the eventual recurrence and succumbing to their disease. With the recent release of the Cancer Genome Atlas for ovarian cancer, it was shown that the PI3K/AKT/mTOR pathway was one of the most frequently mutated or altered pathways in patients’ tumors. Researching how the PI3K/AKT/mTOR pathway affects the progression and tumorigensis of ovarian cancer will hopefully lead to new therapies that will increase survival for women. This review focuses on recent research on the PI3K/AKT/mTOR pathway and its role in the progression and tumorigensis of ovarian cancer.
Keywords: ovarian cancer; PI3K; mTOR; AKT
PDF Full-text Download PDF Full-Text [197 KB, uploaded 19 June 2014 04:49 CEST]

Export to BibTeX |
EndNote


MDPI and ACS Style

Dobbin, Z.C.; Landen, C.N. The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer. Int. J. Mol. Sci. 2013, 14, 8213-8227.

AMA Style

Dobbin ZC, Landen CN. The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer. International Journal of Molecular Sciences. 2013; 14(4):8213-8227.

Chicago/Turabian Style

Dobbin, Zachary C.; Landen, Charles N. 2013. "The Importance of the PI3K/AKT/MTOR Pathway in the Progression of Ovarian Cancer." Int. J. Mol. Sci. 14, no. 4: 8213-8227.


Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert